Heart transplantation in patients with localized prostate cancer-Are we denying a life-saving therapy due to an indolent tumor?

Jayant K RaikhelkarMichael PhamLaura LourencoNikhil NarangBen ChungAnn NguyenGene KimGabriel SayerNir Uriel

Published in: Clinical transplantation (2020)

An overwhelming majority of HTCs in the United States do not consider HT an option for AHF patients with concurrent LPC and lack a formal policy regarding the same.

Keyphrases

prostate cancer
radical prostatectomy
public health
healthcare
mental health
squamous cell carcinoma
radiation therapy
mesenchymal stem cells
smoking cessation